RxDoctor Payments Data

Darryel Wilson, MD

Family Medicine · Covington, GANPI 1285291286

Payments from drug & device makers

$1,709in general payments, 2019–2025

Across 92 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$505
  • AstraZeneca$206
  • Lilly USA, LLC$165
  • Amgen$137
  • Exact Sciences$133
  • Bayer$121
  • plus $443 from 12 others

What the payments were for

  • Food & beverage$1,709100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,709 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$43,989
Medicare patients
160
Services billed
570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$112,906
JardianceEmpagliflozin72$97,365
EliquisApixaban68$76,033
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$43,190
RybelsusSemaglutide21$42,831
TrulicityDulaglutide25$31,727
FarxigaDapagliflozin Propanediol19$24,790
JanuviaSitagliptin Phosphate12$16,673
MounjaroTirzepatide14$14,623
Tresiba Flextouch U-100Insulin Degludec17$8,469
Gabapentin202$4,850
Albuterol Sulfate HfaAlbuterol Sulfate149$4,336
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$4,166
Atorvastatin Calcium447$3,801
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,657

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog Mix 70-30$505$157,386120 claims
Boehringer IngelheimJardiance$21$97,36572 claims
PfizerEliquis$78$76,03368 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$165$49,80354 claims
GSKTrelegy Ellipta$44$43,19056 claims
AstraZenecaFarxiga$206$24,79019 claims
MerckJanuvia$25$16,67312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Covington

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →